Buscar
-
Systemic sclerosis overlap and non-overlap syndromes share clinical characteristics but differ in prognosis and treatments
(Seminars in Arthritis and Rheumatism. vol. 51, n° 1, pp. 36-42, 2021-02)Article de revue -
Update on the cellular pathogenesis of lupus
(Current Opinion in Rheumatology. vol. 33, n° 2, pp. 190-196, 2021-03)Article de revue -
Selectins impair regulatory T cell function and contribute to systemic lupus erythematosus pathogenesis
(Science Translational Medicine. vol. 13, n° 600, 2021-06-30)Article de revue -
Eurolupus cyclophosphamide plus repeated pulses of methyl-prednisolone for the induction therapy of class III, IV and V lupus nephritis
(AUTOIMMUNITY REVIEWS. vol. 20, n° 10, 2021)Article de revue -
Soluble CD95L in cancers and chronic inflammatory disorders, a new therapeutic target?
(Biochimica et Biophysica Acta - Reviews on Cancer. vol. 1876, n° 2, 2021)Article de revue -
The impact of clopidogrel on plasma-soluble CD40 ligand levels in systemic lupus erythematosus patients: the CLOPUS phase I/II pilot study
(Joint Bone Spine. pp. 105097, 2020)Article de revue